nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—SLCO1B3—Rosuvastatin—atherosclerosis	0.173	0.23	CbGbCtD
Atazanavir—SLCO1B3—Pravastatin—atherosclerosis	0.157	0.209	CbGbCtD
Atazanavir—ABCC1—Rosuvastatin—atherosclerosis	0.119	0.159	CbGbCtD
Atazanavir—CYP2C9—Rosuvastatin—atherosclerosis	0.0297	0.0396	CbGbCtD
Atazanavir—ABCB1—Ezetimibe—atherosclerosis	0.0288	0.0384	CbGbCtD
Atazanavir—CYP2C9—Simvastatin—atherosclerosis	0.0276	0.0368	CbGbCtD
Atazanavir—CYP2C9—Pravastatin—atherosclerosis	0.027	0.036	CbGbCtD
Atazanavir—CYP2C9—Lovastatin—atherosclerosis	0.027	0.036	CbGbCtD
Atazanavir—ABCB1—Simvastatin—atherosclerosis	0.0268	0.0357	CbGbCtD
Atazanavir—ABCB1—Lovastatin—atherosclerosis	0.0262	0.0349	CbGbCtD
Atazanavir—ABCB1—Pravastatin—atherosclerosis	0.0262	0.0349	CbGbCtD
Atazanavir—CYP3A4—Rosuvastatin—atherosclerosis	0.0173	0.023	CbGbCtD
Atazanavir—CYP3A4—Ezetimibe—atherosclerosis	0.0173	0.023	CbGbCtD
Atazanavir—CYP3A4—Simvastatin—atherosclerosis	0.016	0.0214	CbGbCtD
Atazanavir—CYP3A4—Lovastatin—atherosclerosis	0.0157	0.0209	CbGbCtD
Atazanavir—CYP3A4—Pravastatin—atherosclerosis	0.0157	0.0209	CbGbCtD
Atazanavir—Jaundice—Pravastatin—atherosclerosis	0.00043	0.00233	CcSEcCtD
Atazanavir—Sweating—Niacin—atherosclerosis	0.00043	0.00232	CcSEcCtD
Atazanavir—Urinary tract infection—Pravastatin—atherosclerosis	0.000429	0.00232	CcSEcCtD
Atazanavir—Cough—Rosuvastatin—atherosclerosis	0.00042	0.00227	CcSEcCtD
Atazanavir—Angiopathy—Ezetimibe—atherosclerosis	0.000417	0.00226	CcSEcCtD
Atazanavir—Immune system disorder—Ezetimibe—atherosclerosis	0.000415	0.00225	CcSEcCtD
Atazanavir—Erythema multiforme—Simvastatin—atherosclerosis	0.000414	0.00224	CcSEcCtD
Atazanavir—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000414	0.00224	CcSEcCtD
Atazanavir—Alopecia—Lovastatin—atherosclerosis	0.000414	0.00224	CcSEcCtD
Atazanavir—Arthralgia—Rosuvastatin—atherosclerosis	0.00041	0.00222	CcSEcCtD
Atazanavir—Myalgia—Rosuvastatin—atherosclerosis	0.00041	0.00222	CcSEcCtD
Atazanavir—Alopecia—Ezetimibe—atherosclerosis	0.000406	0.0022	CcSEcCtD
Atazanavir—Mental disorder—Ezetimibe—atherosclerosis	0.000403	0.00218	CcSEcCtD
Atazanavir—Hepatitis—Niacin—atherosclerosis	0.000403	0.00218	CcSEcCtD
Atazanavir—Flatulence—Lovastatin—atherosclerosis	0.000402	0.00217	CcSEcCtD
Atazanavir—Hypoaesthesia—Niacin—atherosclerosis	0.000401	0.00217	CcSEcCtD
Atazanavir—Malnutrition—Ezetimibe—atherosclerosis	0.0004	0.00216	CcSEcCtD
Atazanavir—Dysgeusia—Lovastatin—atherosclerosis	0.0004	0.00216	CcSEcCtD
Atazanavir—Oedema peripheral—Niacin—atherosclerosis	0.000397	0.00214	CcSEcCtD
Atazanavir—Hepatitis—Pravastatin—atherosclerosis	0.000396	0.00214	CcSEcCtD
Atazanavir—Confusional state—Rosuvastatin—atherosclerosis	0.000396	0.00214	CcSEcCtD
Atazanavir—Back pain—Lovastatin—atherosclerosis	0.000395	0.00213	CcSEcCtD
Atazanavir—Hypoaesthesia—Pravastatin—atherosclerosis	0.000394	0.00213	CcSEcCtD
Atazanavir—Flatulence—Ezetimibe—atherosclerosis	0.000394	0.00213	CcSEcCtD
Atazanavir—Infection—Rosuvastatin—atherosclerosis	0.00039	0.00211	CcSEcCtD
Atazanavir—Alopecia—Simvastatin—atherosclerosis	0.000387	0.00209	CcSEcCtD
Atazanavir—Back pain—Ezetimibe—atherosclerosis	0.000387	0.00209	CcSEcCtD
Atazanavir—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000385	0.00208	CcSEcCtD
Atazanavir—Mental disorder—Simvastatin—atherosclerosis	0.000384	0.00208	CcSEcCtD
Atazanavir—Ill-defined disorder—Lovastatin—atherosclerosis	0.000379	0.00205	CcSEcCtD
Atazanavir—Eye disorder—Niacin—atherosclerosis	0.000376	0.00203	CcSEcCtD
Atazanavir—Flatulence—Simvastatin—atherosclerosis	0.000376	0.00203	CcSEcCtD
Atazanavir—Tinnitus—Niacin—atherosclerosis	0.000375	0.00203	CcSEcCtD
Atazanavir—Erythema multiforme—Pravastatin—atherosclerosis	0.000375	0.00203	CcSEcCtD
Atazanavir—Dysgeusia—Simvastatin—atherosclerosis	0.000374	0.00202	CcSEcCtD
Atazanavir—Angioedema—Lovastatin—atherosclerosis	0.000373	0.00202	CcSEcCtD
Atazanavir—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000371	0.00201	CcSEcCtD
Atazanavir—Tinnitus—Pravastatin—atherosclerosis	0.00037	0.002	CcSEcCtD
Atazanavir—Malaise—Lovastatin—atherosclerosis	0.000368	0.00199	CcSEcCtD
Atazanavir—Cardiac disorder—Pravastatin—atherosclerosis	0.000368	0.00199	CcSEcCtD
Atazanavir—Angioedema—Ezetimibe—atherosclerosis	0.000366	0.00198	CcSEcCtD
Atazanavir—Angiopathy—Niacin—atherosclerosis	0.000365	0.00197	CcSEcCtD
Atazanavir—Malaise—Ezetimibe—atherosclerosis	0.000361	0.00195	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000358	0.00194	CcSEcCtD
Atazanavir—Alopecia—Niacin—atherosclerosis	0.000356	0.00192	CcSEcCtD
Atazanavir—Insomnia—Rosuvastatin—atherosclerosis	0.000355	0.00192	CcSEcCtD
Atazanavir—Ill-defined disorder—Simvastatin—atherosclerosis	0.000354	0.00191	CcSEcCtD
Atazanavir—Palpitations—Ezetimibe—atherosclerosis	0.000354	0.00191	CcSEcCtD
Atazanavir—Malnutrition—Niacin—atherosclerosis	0.00035	0.00189	CcSEcCtD
Atazanavir—Alopecia—Pravastatin—atherosclerosis	0.00035	0.00189	CcSEcCtD
Atazanavir—Cough—Ezetimibe—atherosclerosis	0.000349	0.00189	CcSEcCtD
Atazanavir—Angioedema—Simvastatin—atherosclerosis	0.000349	0.00189	CcSEcCtD
Atazanavir—Myalgia—Lovastatin—atherosclerosis	0.000347	0.00188	CcSEcCtD
Atazanavir—Arthralgia—Lovastatin—atherosclerosis	0.000347	0.00188	CcSEcCtD
Atazanavir—Chest pain—Lovastatin—atherosclerosis	0.000347	0.00188	CcSEcCtD
Atazanavir—Anxiety—Lovastatin—atherosclerosis	0.000346	0.00187	CcSEcCtD
Atazanavir—Dyspepsia—Rosuvastatin—atherosclerosis	0.000346	0.00187	CcSEcCtD
Atazanavir—Hypertension—Ezetimibe—atherosclerosis	0.000345	0.00187	CcSEcCtD
Atazanavir—Flatulence—Niacin—atherosclerosis	0.000345	0.00187	CcSEcCtD
Atazanavir—Malaise—Simvastatin—atherosclerosis	0.000344	0.00186	CcSEcCtD
Atazanavir—Tension—Niacin—atherosclerosis	0.000344	0.00186	CcSEcCtD
Atazanavir—Discomfort—Lovastatin—atherosclerosis	0.000343	0.00186	CcSEcCtD
Atazanavir—Arthralgia—Ezetimibe—atherosclerosis	0.000341	0.00184	CcSEcCtD
Atazanavir—Chest pain—Ezetimibe—atherosclerosis	0.000341	0.00184	CcSEcCtD
Atazanavir—Myalgia—Ezetimibe—atherosclerosis	0.000341	0.00184	CcSEcCtD
Atazanavir—Nervousness—Niacin—atherosclerosis	0.00034	0.00184	CcSEcCtD
Atazanavir—Flatulence—Pravastatin—atherosclerosis	0.00034	0.00184	CcSEcCtD
Atazanavir—Dry mouth—Lovastatin—atherosclerosis	0.00034	0.00184	CcSEcCtD
Atazanavir—Tension—Pravastatin—atherosclerosis	0.000339	0.00183	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000338	0.00183	CcSEcCtD
Atazanavir—Dysgeusia—Pravastatin—atherosclerosis	0.000338	0.00183	CcSEcCtD
Atazanavir—Discomfort—Ezetimibe—atherosclerosis	0.000337	0.00182	CcSEcCtD
Atazanavir—Constipation—Rosuvastatin—atherosclerosis	0.000336	0.00182	CcSEcCtD
Atazanavir—Pain—Rosuvastatin—atherosclerosis	0.000336	0.00182	CcSEcCtD
Atazanavir—Confusional state—Lovastatin—atherosclerosis	0.000336	0.00182	CcSEcCtD
Atazanavir—Nervousness—Pravastatin—atherosclerosis	0.000335	0.00181	CcSEcCtD
Atazanavir—Dry mouth—Ezetimibe—atherosclerosis	0.000333	0.0018	CcSEcCtD
Atazanavir—Infection—Lovastatin—atherosclerosis	0.000331	0.00179	CcSEcCtD
Atazanavir—Confusional state—Ezetimibe—atherosclerosis	0.000329	0.00178	CcSEcCtD
Atazanavir—Chest pain—Simvastatin—atherosclerosis	0.000325	0.00176	CcSEcCtD
Atazanavir—Arthralgia—Simvastatin—atherosclerosis	0.000325	0.00176	CcSEcCtD
Atazanavir—Myalgia—Simvastatin—atherosclerosis	0.000325	0.00176	CcSEcCtD
Atazanavir—Infection—Ezetimibe—atherosclerosis	0.000324	0.00175	CcSEcCtD
Atazanavir—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000324	0.00175	CcSEcCtD
Atazanavir—Anxiety—Simvastatin—atherosclerosis	0.000324	0.00175	CcSEcCtD
Atazanavir—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000321	0.00174	CcSEcCtD
Atazanavir—Discomfort—Simvastatin—atherosclerosis	0.000321	0.00174	CcSEcCtD
Atazanavir—Nervous system disorder—Ezetimibe—atherosclerosis	0.00032	0.00173	CcSEcCtD
Atazanavir—Angioedema—Niacin—atherosclerosis	0.00032	0.00173	CcSEcCtD
Atazanavir—Ill-defined disorder—Pravastatin—atherosclerosis	0.00032	0.00173	CcSEcCtD
Atazanavir—Anorexia—Lovastatin—atherosclerosis	0.000317	0.00172	CcSEcCtD
Atazanavir—Skin disorder—Ezetimibe—atherosclerosis	0.000317	0.00172	CcSEcCtD
Atazanavir—Angioedema—Pravastatin—atherosclerosis	0.000315	0.0017	CcSEcCtD
Atazanavir—Syncope—Niacin—atherosclerosis	0.000314	0.0017	CcSEcCtD
Atazanavir—Confusional state—Simvastatin—atherosclerosis	0.000314	0.0017	CcSEcCtD
Atazanavir—Urticaria—Rosuvastatin—atherosclerosis	0.000312	0.00169	CcSEcCtD
Atazanavir—Oedema—Simvastatin—atherosclerosis	0.000311	0.00168	CcSEcCtD
Atazanavir—Malaise—Pravastatin—atherosclerosis	0.000311	0.00168	CcSEcCtD
Atazanavir—Abdominal pain—Rosuvastatin—atherosclerosis	0.000311	0.00168	CcSEcCtD
Atazanavir—Palpitations—Niacin—atherosclerosis	0.00031	0.00167	CcSEcCtD
Atazanavir—Infection—Simvastatin—atherosclerosis	0.000309	0.00167	CcSEcCtD
Atazanavir—Loss of consciousness—Niacin—atherosclerosis	0.000308	0.00167	CcSEcCtD
Atazanavir—Cough—Niacin—atherosclerosis	0.000306	0.00165	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000303	0.00164	CcSEcCtD
Atazanavir—Insomnia—Lovastatin—atherosclerosis	0.000301	0.00163	CcSEcCtD
Atazanavir—Cough—Pravastatin—atherosclerosis	0.000301	0.00163	CcSEcCtD
Atazanavir—Arthralgia—Niacin—atherosclerosis	0.000298	0.00161	CcSEcCtD
Atazanavir—Myalgia—Niacin—atherosclerosis	0.000298	0.00161	CcSEcCtD
Atazanavir—Hypertension—Pravastatin—atherosclerosis	0.000298	0.00161	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000298	0.00161	CcSEcCtD
Atazanavir—Anorexia—Simvastatin—atherosclerosis	0.000297	0.00161	CcSEcCtD
Atazanavir—Dyspnoea—Lovastatin—atherosclerosis	0.000297	0.00161	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000296	0.0016	CcSEcCtD
Atazanavir—Insomnia—Ezetimibe—atherosclerosis	0.000295	0.0016	CcSEcCtD
Atazanavir—Arthralgia—Pravastatin—atherosclerosis	0.000294	0.00159	CcSEcCtD
Atazanavir—Chest pain—Pravastatin—atherosclerosis	0.000294	0.00159	CcSEcCtD
Atazanavir—Myalgia—Pravastatin—atherosclerosis	0.000294	0.00159	CcSEcCtD
Atazanavir—Dyspepsia—Lovastatin—atherosclerosis	0.000293	0.00159	CcSEcCtD
Atazanavir—Anxiety—Pravastatin—atherosclerosis	0.000293	0.00158	CcSEcCtD
Atazanavir—Dry mouth—Niacin—atherosclerosis	0.000292	0.00158	CcSEcCtD
Atazanavir—Dyspnoea—Ezetimibe—atherosclerosis	0.000291	0.00157	CcSEcCtD
Atazanavir—Discomfort—Pravastatin—atherosclerosis	0.00029	0.00157	CcSEcCtD
Atazanavir—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000289	0.00157	CcSEcCtD
Atazanavir—Decreased appetite—Lovastatin—atherosclerosis	0.000289	0.00157	CcSEcCtD
Atazanavir—Dyspepsia—Ezetimibe—atherosclerosis	0.000287	0.00155	CcSEcCtD
Atazanavir—Fatigue—Lovastatin—atherosclerosis	0.000287	0.00155	CcSEcCtD
Atazanavir—Oedema—Niacin—atherosclerosis	0.000286	0.00155	CcSEcCtD
Atazanavir—Pain—Lovastatin—atherosclerosis	0.000285	0.00154	CcSEcCtD
Atazanavir—Constipation—Lovastatin—atherosclerosis	0.000285	0.00154	CcSEcCtD
Atazanavir—Confusional state—Pravastatin—atherosclerosis	0.000284	0.00154	CcSEcCtD
Atazanavir—Decreased appetite—Ezetimibe—atherosclerosis	0.000284	0.00154	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000284	0.00153	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000282	0.00152	CcSEcCtD
Atazanavir—Asthenia—Rosuvastatin—atherosclerosis	0.000282	0.00152	CcSEcCtD
Atazanavir—Insomnia—Simvastatin—atherosclerosis	0.000282	0.00152	CcSEcCtD
Atazanavir—Oedema—Pravastatin—atherosclerosis	0.000282	0.00152	CcSEcCtD
Atazanavir—Fatigue—Ezetimibe—atherosclerosis	0.000282	0.00152	CcSEcCtD
Atazanavir—Shock—Niacin—atherosclerosis	0.000281	0.00152	CcSEcCtD
Atazanavir—Infection—Pravastatin—atherosclerosis	0.00028	0.00151	CcSEcCtD
Atazanavir—Pain—Ezetimibe—atherosclerosis	0.000279	0.00151	CcSEcCtD
Atazanavir—Constipation—Ezetimibe—atherosclerosis	0.000279	0.00151	CcSEcCtD
Atazanavir—Pruritus—Rosuvastatin—atherosclerosis	0.000278	0.0015	CcSEcCtD
Atazanavir—Skin disorder—Niacin—atherosclerosis	0.000278	0.0015	CcSEcCtD
Atazanavir—Dyspnoea—Simvastatin—atherosclerosis	0.000278	0.0015	CcSEcCtD
Atazanavir—Hyperhidrosis—Niacin—atherosclerosis	0.000276	0.0015	CcSEcCtD
Atazanavir—Feeling abnormal—Lovastatin—atherosclerosis	0.000274	0.00148	CcSEcCtD
Atazanavir—Dyspepsia—Simvastatin—atherosclerosis	0.000274	0.00148	CcSEcCtD
Atazanavir—Anorexia—Niacin—atherosclerosis	0.000273	0.00147	CcSEcCtD
Atazanavir—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000272	0.00147	CcSEcCtD
Atazanavir—Hyperhidrosis—Pravastatin—atherosclerosis	0.000272	0.00147	CcSEcCtD
Atazanavir—Decreased appetite—Simvastatin—atherosclerosis	0.000271	0.00146	CcSEcCtD
Atazanavir—Feeling abnormal—Ezetimibe—atherosclerosis	0.000269	0.00146	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000269	0.00145	CcSEcCtD
Atazanavir—Diarrhoea—Rosuvastatin—atherosclerosis	0.000269	0.00145	CcSEcCtD
Atazanavir—Fatigue—Simvastatin—atherosclerosis	0.000269	0.00145	CcSEcCtD
Atazanavir—Anorexia—Pravastatin—atherosclerosis	0.000268	0.00145	CcSEcCtD
Atazanavir—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000267	0.00144	CcSEcCtD
Atazanavir—Constipation—Simvastatin—atherosclerosis	0.000266	0.00144	CcSEcCtD
Atazanavir—Pain—Simvastatin—atherosclerosis	0.000266	0.00144	CcSEcCtD
Atazanavir—Urticaria—Lovastatin—atherosclerosis	0.000265	0.00143	CcSEcCtD
Atazanavir—Abdominal pain—Lovastatin—atherosclerosis	0.000263	0.00142	CcSEcCtD
Atazanavir—Body temperature increased—Lovastatin—atherosclerosis	0.000263	0.00142	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000261	0.00141	CcSEcCtD
Atazanavir—Dizziness—Rosuvastatin—atherosclerosis	0.00026	0.00141	CcSEcCtD
Atazanavir—Urticaria—Ezetimibe—atherosclerosis	0.000259	0.0014	CcSEcCtD
Atazanavir—Insomnia—Niacin—atherosclerosis	0.000259	0.0014	CcSEcCtD
Atazanavir—Body temperature increased—Ezetimibe—atherosclerosis	0.000258	0.0014	CcSEcCtD
Atazanavir—Abdominal pain—Ezetimibe—atherosclerosis	0.000258	0.0014	CcSEcCtD
Atazanavir—Feeling abnormal—Simvastatin—atherosclerosis	0.000257	0.00139	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000257	0.00139	CcSEcCtD
Atazanavir—Dyspnoea—Niacin—atherosclerosis	0.000255	0.00138	CcSEcCtD
Atazanavir—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000255	0.00138	CcSEcCtD
Atazanavir—Insomnia—Pravastatin—atherosclerosis	0.000255	0.00138	CcSEcCtD
Atazanavir—Somnolence—Niacin—atherosclerosis	0.000254	0.00137	CcSEcCtD
Atazanavir—Dyspepsia—Niacin—atherosclerosis	0.000252	0.00136	CcSEcCtD
Atazanavir—Dyspnoea—Pravastatin—atherosclerosis	0.000251	0.00136	CcSEcCtD
Atazanavir—Decreased appetite—Niacin—atherosclerosis	0.000249	0.00134	CcSEcCtD
Atazanavir—Dyspepsia—Pravastatin—atherosclerosis	0.000248	0.00134	CcSEcCtD
Atazanavir—Rash—Rosuvastatin—atherosclerosis	0.000248	0.00134	CcSEcCtD
Atazanavir—Dermatitis—Rosuvastatin—atherosclerosis	0.000248	0.00134	CcSEcCtD
Atazanavir—Urticaria—Simvastatin—atherosclerosis	0.000247	0.00134	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Niacin—atherosclerosis	0.000247	0.00134	CcSEcCtD
Atazanavir—Abdominal pain—Simvastatin—atherosclerosis	0.000246	0.00133	CcSEcCtD
Atazanavir—Body temperature increased—Simvastatin—atherosclerosis	0.000246	0.00133	CcSEcCtD
Atazanavir—Headache—Rosuvastatin—atherosclerosis	0.000246	0.00133	CcSEcCtD
Atazanavir—Hypersensitivity—Lovastatin—atherosclerosis	0.000245	0.00133	CcSEcCtD
Atazanavir—Decreased appetite—Pravastatin—atherosclerosis	0.000245	0.00132	CcSEcCtD
Atazanavir—Pain—Niacin—atherosclerosis	0.000245	0.00132	CcSEcCtD
Atazanavir—Fatigue—Pravastatin—atherosclerosis	0.000243	0.00131	CcSEcCtD
Atazanavir—Constipation—Pravastatin—atherosclerosis	0.000241	0.0013	CcSEcCtD
Atazanavir—Pain—Pravastatin—atherosclerosis	0.000241	0.0013	CcSEcCtD
Atazanavir—Hypersensitivity—Ezetimibe—atherosclerosis	0.000241	0.0013	CcSEcCtD
Atazanavir—Asthenia—Lovastatin—atherosclerosis	0.000239	0.00129	CcSEcCtD
Atazanavir—Pruritus—Lovastatin—atherosclerosis	0.000236	0.00127	CcSEcCtD
Atazanavir—Asthenia—Ezetimibe—atherosclerosis	0.000234	0.00127	CcSEcCtD
Atazanavir—Gastrointestinal pain—Niacin—atherosclerosis	0.000234	0.00126	CcSEcCtD
Atazanavir—Nausea—Rosuvastatin—atherosclerosis	0.000233	0.00126	CcSEcCtD
Atazanavir—Feeling abnormal—Pravastatin—atherosclerosis	0.000232	0.00125	CcSEcCtD
Atazanavir—Pruritus—Ezetimibe—atherosclerosis	0.000231	0.00125	CcSEcCtD
Atazanavir—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00023	0.00125	CcSEcCtD
Atazanavir—Hypersensitivity—Simvastatin—atherosclerosis	0.000229	0.00124	CcSEcCtD
Atazanavir—Diarrhoea—Lovastatin—atherosclerosis	0.000228	0.00123	CcSEcCtD
Atazanavir—Urticaria—Niacin—atherosclerosis	0.000227	0.00123	CcSEcCtD
Atazanavir—Abdominal pain—Niacin—atherosclerosis	0.000226	0.00122	CcSEcCtD
Atazanavir—Body temperature increased—Niacin—atherosclerosis	0.000226	0.00122	CcSEcCtD
Atazanavir—Urticaria—Pravastatin—atherosclerosis	0.000224	0.00121	CcSEcCtD
Atazanavir—Asthenia—Simvastatin—atherosclerosis	0.000223	0.00121	CcSEcCtD
Atazanavir—Diarrhoea—Ezetimibe—atherosclerosis	0.000223	0.00121	CcSEcCtD
Atazanavir—Body temperature increased—Pravastatin—atherosclerosis	0.000223	0.0012	CcSEcCtD
Atazanavir—Abdominal pain—Pravastatin—atherosclerosis	0.000223	0.0012	CcSEcCtD
Atazanavir—Pruritus—Simvastatin—atherosclerosis	0.00022	0.00119	CcSEcCtD
Atazanavir—Dizziness—Lovastatin—atherosclerosis	0.00022	0.00119	CcSEcCtD
Atazanavir—Dizziness—Ezetimibe—atherosclerosis	0.000216	0.00117	CcSEcCtD
Atazanavir—Diarrhoea—Simvastatin—atherosclerosis	0.000213	0.00115	CcSEcCtD
Atazanavir—Vomiting—Lovastatin—atherosclerosis	0.000212	0.00114	CcSEcCtD
Atazanavir—Hypersensitivity—Niacin—atherosclerosis	0.000211	0.00114	CcSEcCtD
Atazanavir—Rash—Lovastatin—atherosclerosis	0.00021	0.00114	CcSEcCtD
Atazanavir—Dermatitis—Lovastatin—atherosclerosis	0.00021	0.00113	CcSEcCtD
Atazanavir—Headache—Lovastatin—atherosclerosis	0.000209	0.00113	CcSEcCtD
Atazanavir—Vomiting—Ezetimibe—atherosclerosis	0.000208	0.00112	CcSEcCtD
Atazanavir—Hypersensitivity—Pravastatin—atherosclerosis	0.000207	0.00112	CcSEcCtD
Atazanavir—Dizziness—Simvastatin—atherosclerosis	0.000206	0.00111	CcSEcCtD
Atazanavir—Rash—Ezetimibe—atherosclerosis	0.000206	0.00111	CcSEcCtD
Atazanavir—Dermatitis—Ezetimibe—atherosclerosis	0.000206	0.00111	CcSEcCtD
Atazanavir—Asthenia—Niacin—atherosclerosis	0.000205	0.00111	CcSEcCtD
Atazanavir—Headache—Ezetimibe—atherosclerosis	0.000205	0.00111	CcSEcCtD
Atazanavir—Pruritus—Niacin—atherosclerosis	0.000202	0.00109	CcSEcCtD
Atazanavir—Asthenia—Pravastatin—atherosclerosis	0.000202	0.00109	CcSEcCtD
Atazanavir—Pruritus—Pravastatin—atherosclerosis	0.000199	0.00108	CcSEcCtD
Atazanavir—Vomiting—Simvastatin—atherosclerosis	0.000198	0.00107	CcSEcCtD
Atazanavir—Nausea—Lovastatin—atherosclerosis	0.000198	0.00107	CcSEcCtD
Atazanavir—Rash—Simvastatin—atherosclerosis	0.000196	0.00106	CcSEcCtD
Atazanavir—Dermatitis—Simvastatin—atherosclerosis	0.000196	0.00106	CcSEcCtD
Atazanavir—Diarrhoea—Niacin—atherosclerosis	0.000196	0.00106	CcSEcCtD
Atazanavir—Headache—Simvastatin—atherosclerosis	0.000195	0.00106	CcSEcCtD
Atazanavir—Nausea—Ezetimibe—atherosclerosis	0.000194	0.00105	CcSEcCtD
Atazanavir—Diarrhoea—Pravastatin—atherosclerosis	0.000193	0.00104	CcSEcCtD
Atazanavir—Dizziness—Niacin—atherosclerosis	0.000189	0.00102	CcSEcCtD
Atazanavir—Dizziness—Pravastatin—atherosclerosis	0.000186	0.00101	CcSEcCtD
Atazanavir—Nausea—Simvastatin—atherosclerosis	0.000185	0.001	CcSEcCtD
Atazanavir—Vomiting—Niacin—atherosclerosis	0.000182	0.000983	CcSEcCtD
Atazanavir—Rash—Niacin—atherosclerosis	0.00018	0.000975	CcSEcCtD
Atazanavir—Dermatitis—Niacin—atherosclerosis	0.00018	0.000974	CcSEcCtD
Atazanavir—Headache—Niacin—atherosclerosis	0.000179	0.000969	CcSEcCtD
Atazanavir—Vomiting—Pravastatin—atherosclerosis	0.000179	0.000968	CcSEcCtD
Atazanavir—Rash—Pravastatin—atherosclerosis	0.000178	0.00096	CcSEcCtD
Atazanavir—Dermatitis—Pravastatin—atherosclerosis	0.000177	0.000959	CcSEcCtD
Atazanavir—Headache—Pravastatin—atherosclerosis	0.000176	0.000954	CcSEcCtD
Atazanavir—Nausea—Niacin—atherosclerosis	0.00017	0.000919	CcSEcCtD
Atazanavir—Nausea—Pravastatin—atherosclerosis	0.000167	0.000904	CcSEcCtD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	3.34e-05	0.000514	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.33e-05	0.000513	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PLTP—atherosclerosis	3.32e-05	0.000512	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	3.29e-05	0.000506	CbGpPWpGaD
Atazanavir—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	3.25e-05	0.000501	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	3.24e-05	0.000499	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CYBA—atherosclerosis	3.2e-05	0.000493	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.2e-05	0.000492	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PARP1—atherosclerosis	3.13e-05	0.000482	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—NAMPT—atherosclerosis	3.11e-05	0.000478	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.09e-05	0.000475	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—LIPC—atherosclerosis	3.09e-05	0.000475	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ABCG8—atherosclerosis	3.09e-05	0.000475	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—LTA4H—atherosclerosis	3.09e-05	0.000475	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	3.08e-05	0.000474	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—APOC3—atherosclerosis	3.07e-05	0.000472	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	3.06e-05	0.000471	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—LDLR—atherosclerosis	3.05e-05	0.000469	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	3.04e-05	0.000468	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	3.02e-05	0.000465	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CETP—atherosclerosis	2.98e-05	0.000458	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	2.97e-05	0.000457	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—HMOX1—atherosclerosis	2.91e-05	0.000448	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCG8—atherosclerosis	2.88e-05	0.000444	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—LTA4H—atherosclerosis	2.88e-05	0.000444	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—SCARB1—atherosclerosis	2.85e-05	0.000439	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.85e-05	0.000438	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—APOB—atherosclerosis	2.79e-05	0.000429	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.78e-05	0.000427	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	2.77e-05	0.000426	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GSTM1—atherosclerosis	2.71e-05	0.000418	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—HMGCR—atherosclerosis	2.69e-05	0.000414	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.69e-05	0.000414	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	2.67e-05	0.00041	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—LPL—atherosclerosis	2.66e-05	0.00041	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.64e-05	0.000406	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GPX1—atherosclerosis	2.6e-05	0.0004	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CD36—atherosclerosis	2.53e-05	0.00039	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ABCG1—atherosclerosis	2.44e-05	0.000375	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.43e-05	0.000374	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	2.4e-05	0.00037	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ABCA1—atherosclerosis	2.4e-05	0.000369	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—MTHFR—atherosclerosis	2.4e-05	0.000369	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.4e-05	0.000369	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	2.36e-05	0.000363	CbGpPWpGaD
Atazanavir—ABCC1—Disease—APOB—atherosclerosis	2.36e-05	0.000362	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PPARA—atherosclerosis	2.35e-05	0.000362	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.33e-05	0.000359	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—FABP4—atherosclerosis	2.29e-05	0.000353	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—LCAT—atherosclerosis	2.29e-05	0.000353	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—AGT—atherosclerosis	2.28e-05	0.000351	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCG1—atherosclerosis	2.28e-05	0.000351	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	2.27e-05	0.000349	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APOA4—atherosclerosis	2.25e-05	0.000346	CbGpPWpGaD
Atazanavir—ABCC1—Disease—LPL—atherosclerosis	2.25e-05	0.000346	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—APOE—atherosclerosis	2.23e-05	0.000344	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CAV1—atherosclerosis	2.21e-05	0.00034	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP7A1—atherosclerosis	2.21e-05	0.00034	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—APOA1—atherosclerosis	2.21e-05	0.00034	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PLTP—atherosclerosis	2.19e-05	0.000337	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PRKCG—atherosclerosis	2.19e-05	0.000337	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	2.18e-05	0.000335	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—FABP4—atherosclerosis	2.14e-05	0.00033	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—LCAT—atherosclerosis	2.14e-05	0.00033	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOA4—atherosclerosis	2.1e-05	0.000324	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.09e-05	0.000322	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP7A1—atherosclerosis	2.07e-05	0.000318	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	2.06e-05	0.000317	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—HMOX1—atherosclerosis	2.06e-05	0.000317	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP27A1—atherosclerosis	2.04e-05	0.000315	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MTHFR—atherosclerosis	2.02e-05	0.000312	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CG—atherosclerosis	2.02e-05	0.00031	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	2e-05	0.000308	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	2e-05	0.000308	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—APOB—atherosclerosis	1.97e-05	0.000304	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PDGFB—atherosclerosis	1.97e-05	0.000303	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.97e-05	0.000303	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PPARG—atherosclerosis	1.94e-05	0.000299	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.94e-05	0.000298	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALOX15—atherosclerosis	1.94e-05	0.000298	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.94e-05	0.000298	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APOA2—atherosclerosis	1.94e-05	0.000298	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTM1—atherosclerosis	1.92e-05	0.000295	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ABCG5—atherosclerosis	1.91e-05	0.000295	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.91e-05	0.000294	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—INS—atherosclerosis	1.91e-05	0.000294	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.9e-05	0.000293	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.9e-05	0.000293	CbGpPWpGaD
Atazanavir—ABCC1—Disease—APOE—atherosclerosis	1.89e-05	0.00029	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—LPL—atherosclerosis	1.88e-05	0.00029	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.88e-05	0.000289	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.87e-05	0.000288	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CAV1—atherosclerosis	1.87e-05	0.000287	CbGpPWpGaD
Atazanavir—ABCC1—Disease—APOA1—atherosclerosis	1.86e-05	0.000287	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—LPA—atherosclerosis	1.85e-05	0.000284	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GPX1—atherosclerosis	1.84e-05	0.000283	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.83e-05	0.000282	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOA2—atherosclerosis	1.81e-05	0.000279	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.81e-05	0.000279	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.81e-05	0.000279	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.81e-05	0.000279	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—BGN—atherosclerosis	1.79e-05	0.000275	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CD36—atherosclerosis	1.79e-05	0.000275	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.79e-05	0.000275	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.79e-05	0.000275	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APOA5—atherosclerosis	1.77e-05	0.000273	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NOS2—atherosclerosis	1.76e-05	0.00027	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ALB—atherosclerosis	1.75e-05	0.000269	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—LPA—atherosclerosis	1.73e-05	0.000266	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.71e-05	0.000262	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—MTHFR—atherosclerosis	1.7e-05	0.000261	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.69e-05	0.00026	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—NOS3—atherosclerosis	1.67e-05	0.000257	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—BGN—atherosclerosis	1.67e-05	0.000257	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PPARA—atherosclerosis	1.66e-05	0.000256	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.66e-05	0.000256	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOA5—atherosclerosis	1.66e-05	0.000255	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALOX5—atherosclerosis	1.65e-05	0.000254	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—AGT—atherosclerosis	1.61e-05	0.000248	CbGpPWpGaD
Atazanavir—ABCC1—Disease—INS—atherosclerosis	1.61e-05	0.000248	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.61e-05	0.000247	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.59e-05	0.000245	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.59e-05	0.000244	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—APOE—atherosclerosis	1.58e-05	0.000243	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.58e-05	0.000242	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CAV1—atherosclerosis	1.56e-05	0.000241	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.56e-05	0.00024	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—APOA1—atherosclerosis	1.56e-05	0.00024	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.56e-05	0.00024	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.54e-05	0.000237	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTGS2—atherosclerosis	1.53e-05	0.000235	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.5e-05	0.000231	CbGpPWpGaD
Atazanavir—ABCC1—Disease—SERPINE1—atherosclerosis	1.48e-05	0.000228	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NAMPT—atherosclerosis	1.48e-05	0.000227	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—LIPC—atherosclerosis	1.47e-05	0.000226	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APOC3—atherosclerosis	1.46e-05	0.000225	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—LDLR—atherosclerosis	1.45e-05	0.000223	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CG—atherosclerosis	1.42e-05	0.000219	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.42e-05	0.000219	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CETP—atherosclerosis	1.42e-05	0.000218	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LCAT—atherosclerosis	1.41e-05	0.000217	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—FABP4—atherosclerosis	1.41e-05	0.000217	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NOS3—atherosclerosis	1.41e-05	0.000217	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.39e-05	0.000214	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOA4—atherosclerosis	1.39e-05	0.000213	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.38e-05	0.000212	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PPARG—atherosclerosis	1.38e-05	0.000212	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.37e-05	0.000211	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—LIPC—atherosclerosis	1.37e-05	0.000211	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOC3—atherosclerosis	1.36e-05	0.00021	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.36e-05	0.00021	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SCARB1—atherosclerosis	1.36e-05	0.000209	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—LDLR—atherosclerosis	1.35e-05	0.000209	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—INS—atherosclerosis	1.35e-05	0.000208	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CETP—atherosclerosis	1.32e-05	0.000204	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PTGS2—atherosclerosis	1.29e-05	0.000199	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HMGCR—atherosclerosis	1.28e-05	0.000197	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.27e-05	0.000195	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.26e-05	0.000194	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.26e-05	0.000193	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ALB—atherosclerosis	1.24e-05	0.00019	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.23e-05	0.00019	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.2e-05	0.000184	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.19e-05	0.000184	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.19e-05	0.000184	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOA2—atherosclerosis	1.19e-05	0.000184	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.19e-05	0.000184	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—NOS3—atherosclerosis	1.18e-05	0.000182	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.18e-05	0.000181	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ABCA1—atherosclerosis	1.14e-05	0.000176	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LPA—atherosclerosis	1.14e-05	0.000175	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—BGN—atherosclerosis	1.1e-05	0.00017	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOA5—atherosclerosis	1.09e-05	0.000168	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTGS2—atherosclerosis	1.08e-05	0.000166	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.08e-05	0.000166	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.07e-05	0.000164	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.05e-05	0.000162	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.01e-05	0.000156	CbGpPWpGaD
Atazanavir—ABCC1—Disease—STAT3—atherosclerosis	1.01e-05	0.000155	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HMOX1—atherosclerosis	9.8e-06	0.000151	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MAPK3—atherosclerosis	9.62e-06	0.000148	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APOB—atherosclerosis	9.38e-06	0.000144	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TGFB1—atherosclerosis	9.34e-06	0.000144	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HMOX1—atherosclerosis	9.15e-06	0.000141	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTM1—atherosclerosis	9.13e-06	0.00014	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NAMPT—atherosclerosis	9.1e-06	0.00014	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LIPC—atherosclerosis	9.05e-06	0.000139	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOC3—atherosclerosis	8.99e-06	0.000138	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—LPL—atherosclerosis	8.96e-06	0.000138	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LDLR—atherosclerosis	8.94e-06	0.000138	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOB—atherosclerosis	8.77e-06	0.000135	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GPX1—atherosclerosis	8.74e-06	0.000135	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CETP—atherosclerosis	8.73e-06	0.000134	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTM1—atherosclerosis	8.53e-06	0.000131	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CD36—atherosclerosis	8.51e-06	0.000131	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—LPL—atherosclerosis	8.37e-06	0.000129	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SCARB1—atherosclerosis	8.36e-06	0.000129	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GPX1—atherosclerosis	8.17e-06	0.000126	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—MTHFR—atherosclerosis	8.07e-06	0.000124	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CD36—atherosclerosis	7.95e-06	0.000122	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PPARA—atherosclerosis	7.91e-06	0.000122	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HMGCR—atherosclerosis	7.89e-06	0.000121	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—AKT1—atherosclerosis	7.69e-06	0.000118	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AGT—atherosclerosis	7.67e-06	0.000118	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MTHFR—atherosclerosis	7.54e-06	0.000116	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APOE—atherosclerosis	7.51e-06	0.000116	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CAV1—atherosclerosis	7.44e-06	0.000115	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APOA1—atherosclerosis	7.42e-06	0.000114	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PPARA—atherosclerosis	7.39e-06	0.000114	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AGT—atherosclerosis	7.16e-06	0.00011	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IL6—atherosclerosis	7.04e-06	0.000108	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCA1—atherosclerosis	7.04e-06	0.000108	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOE—atherosclerosis	7.02e-06	0.000108	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CAV1—atherosclerosis	6.95e-06	0.000107	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOA1—atherosclerosis	6.94e-06	0.000107	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CG—atherosclerosis	6.78e-06	0.000104	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PPARG—atherosclerosis	6.54e-06	0.000101	CbGpPWpGaD
Atazanavir—ABCC1—Disease—AKT1—atherosclerosis	6.49e-06	9.99e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—INS—atherosclerosis	6.42e-06	9.87e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CG—atherosclerosis	6.33e-06	9.74e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PPARG—atherosclerosis	6.11e-06	9.41e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HMOX1—atherosclerosis	6.04e-06	9.29e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—INS—atherosclerosis	5.99e-06	9.22e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALB—atherosclerosis	5.88e-06	9.05e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOB—atherosclerosis	5.78e-06	8.9e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NOS3—atherosclerosis	5.63e-06	8.66e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.62e-06	8.66e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LPL—atherosclerosis	5.52e-06	8.5e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALB—atherosclerosis	5.5e-06	8.46e-05	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—AKT1—atherosclerosis	5.44e-06	8.37e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GPX1—atherosclerosis	5.39e-06	8.29e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NOS3—atherosclerosis	5.26e-06	8.09e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CD36—atherosclerosis	5.25e-06	8.07e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTGS2—atherosclerosis	5.15e-06	7.92e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.97e-06	7.65e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPARA—atherosclerosis	4.88e-06	7.5e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTGS2—atherosclerosis	4.81e-06	7.4e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AGT—atherosclerosis	4.72e-06	7.27e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOE—atherosclerosis	4.63e-06	7.12e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CAV1—atherosclerosis	4.58e-06	7.06e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOA1—atherosclerosis	4.57e-06	7.04e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.18e-06	6.43e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPARG—atherosclerosis	4.03e-06	6.2e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—INS—atherosclerosis	3.95e-06	6.08e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALB—atherosclerosis	3.62e-06	5.58e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NOS3—atherosclerosis	3.47e-06	5.34e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.17e-06	4.88e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AKT1—atherosclerosis	2.59e-06	3.98e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AKT1—atherosclerosis	2.42e-06	3.72e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AKT1—atherosclerosis	1.59e-06	2.45e-05	CbGpPWpGaD
